Find a Trial

Trial Summary


Protocol No.PHO-DOD-NF110
StatusOPEN TO ACCRUAL
Principal InvestigatorFerguson, Michael
ScopeNational
PhasePhase II
Age GroupAdults and Children
TitleNF110: Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Applicable Disease SitesBrain and Nervous System
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactJennifer Pencek, RN, BSNPhone: +1 317-944-2832
    Pager:
    Email: jpencek@iupui.edu